Bal Pharma Ltd. (BALPHARMA): Bal Pharma Share Price rises 9.70% as stock closes at Rs 110
- September 21, 2026
- Posted by: Harsh Piplani
- Category: News
Bal Pharma Share Price rose sharply today, with Bal Pharma Ltd. closing at Rs 110 after a 9.70% gain from the previous close of Rs 100.27. The company’s market capitalisation stands at Rs 159.64 crore, placing today’s move in a clearly event-led context for Bal Pharma Share Price Today coverage. The session opened at Rs 101.99, touched Rs 110, and recorded a low of Rs 101, while turnover was Rs 0.02 crore. The supplied data confirms a same-day price rise, but it does not establish a company-specific catalyst. For readers tracking Bal Pharma Stock News, the most relevant next checks are the company’s financial ratios, healthcare sector comparison and any later updates that can explain whether this move extends beyond today’s trade.
In Univest’s market coverage, Bal Pharma Share Price matters today because the stock is among the session’s notable gainers on a percentage basis. Univest is tracking the move with a focus on verified price data, market capitalisation and sector context rather than speculation. Investors following Bal Pharma Share Price Live can use the day’s numbers as a factual snapshot: the stock ended at its high of the day, and the move was strong enough to stand out in Bal Pharma Stock News Today searches without requiring a claimed trigger.
Bal Pharma Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 110 |
| Previous Close | Rs 100.27 |
| Today's Move | Rs 9.73 (+9.7%) |
| Open | Rs 101.99 |
| High | Rs 110 |
| Low | Rs 101 |
| Turnover | Rs 0.02 crore |
| Market Capitalisation | Rs 159.64 crore |
| Market Cap Category | Micro Cap |
Bal Pharma Ltd. (BALPHARMA) rose to Rs 110 from the previous close of Rs 100.27, a move of Rs 9.73 or 9.7%. The stock opened at Rs 101.99, reached a high of Rs 110, recorded a low of Rs 101.
Bal Pharma Share Price Today reflects a clear one-day rise from Rs 100.27 to Rs 110, a gain of Rs 9.73 or 9.70%. The stock opened at Rs 101.99, traded between Rs 101 and Rs 110, and finished at the day’s high. Turnover stood at Rs 0.02 crore, which is a factual traded-value figure and should be read alongside the price move rather than as a signal of demand or participation. On the day, Bal Pharma Share Price Update data shows a full-session advance with no verified company-specific reason attached to the move.
For traders and readers scanning Bal Pharma Stock Gaining Today lists, the important point is simple: the stock closed materially above the previous close and ended the session at the top of its range. Univest highlights this as a price rise event first and foremost, with no unsupported catalyst attached. In Indian Stock Market coverage, that makes Bal Pharma Share Price Today relevant for watchers of Stocks in News, even when the supplied data does not explain the cause.
Bal Pharma Ltd. (BALPHARMA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 159.64 crore |
| P/E Ratio | 22.15x |
| P/B Ratio | 1.91x |
| ROE | 7.92% |
| ROCE | 9.78% |
| EPS | Rs 4.53 |
| Book Value Per Share | Rs 52.36 |
| Dividend Yield | 1.2% |
Bal Pharma Ltd. (BALPHARMA) fundamental metrics show P/E 22.15x, P/B 1.91x, ROE 7.92%, ROCE 9.78%. These figures provide context only and are not a buy or sell signal.
Bal Pharma Ltd. has a market capitalisation of Rs 159.64 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 22.15x, P/B at 1.91x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 7.92% and ROCE of 9.78%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 4.53, book value per share of Rs 52.36, dividend yield of 1.2%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.87x, median ROE of 11.7%, median ROCE of 13.46%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 22.15x |
| Benchmark Median P/E | 32.87x |
| Benchmark Average P/E | 48.77x |
| Benchmark P/E Range | 3.4x to 683.5x |
| Company P/B Ratio | 1.91x |
| Benchmark Median P/B | 3.08x |
| Company ROE | 7.92% |
| Benchmark Median ROE | 11.7% |
| Company ROCE | 9.78% |
| Benchmark Median ROCE | 13.46% |
| Company Market Capitalisation | Rs 159.64 crore |
| Benchmark Median Market Cap | Rs 701.78 crore |
Bal Pharma Ltd. (BALPHARMA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Bal Pharma Ltd. (BALPHARMA) has a P/E ratio of 22.15x, which is below the benchmark median of 32.87x, a difference of -32.61%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Bal Pharma Ltd. (BALPHARMA) has a ROE of 7.92%, which is below the benchmark median of 11.7%, a difference of -32.31%. Bal Pharma Ltd. (BALPHARMA) has a ROCE of 9.78%, which is below the benchmark median of 13.46%, a difference of -27.34%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,40,397.93 | 36.41 | 5.09 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,48,664.42 | 85.01 | 14.08 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,82,738.23 | 83.79 | 20.36 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,15,012.19 | 25.48 | 4.27 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,10,793.75 | 32.87 | 3.15 | 11.83 | 16 |
Bal Pharma Ltd. (BALPHARMA) has a P/E ratio of 22.15x compared with the displayed peer median of 36.41x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 7.92% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 9.78% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Bal Pharma Ltd. (BALPHARMA) has a market capitalisation of Rs 159.64 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Bal Pharma
- Bal Pharma Share Price rose 9.70% today to Rs 110, closing at the day’s high of Rs 110.
- The previous close was Rs 100.27, so the absolute change was Rs 9.73 in a single session.
- Market capitalisation stands at Rs 159.64 crore, which gives the move a defined company-size context.
- P/E is 22.15 and P/B is 1.91, both below the same-industry medians of 32.87 and 3.08.
- ROE is 7.92 and ROCE is 9.78, which trail the same-industry medians of 11.7 and 13.46.
About Bal Pharma
Bal Pharma Ltd. operates in Healthcare and the Pharmaceuticals & Drugs industry. The supplied data does not include a broader business description, product breakup or segment mix, so the profile here stays limited to verified classification and financial context. For Bal Pharma Share Price readers, that means the company can be placed correctly within the pharmaceutical universe even when more detailed operating information is not provided in the source set.
Within the supplied market data, Bal Pharma is a listed Indian company with a market capitalisation of Rs 159.64 crore, a P/E of 22.15, a P/B of 1.91, ROE of 7.92 and ROCE of 9.78. EPS is Rs 4.53, book value is Rs 52.36 and dividend yield is 1.2%. Univest includes this section so Bal Pharma Stock News and Bal Pharma Share Price Today coverage remains anchored in company facts, industry classification and measurable fundamentals.
Track Bal Pharma Share Price on Univest
Use Bal Pharma Ltd. (BALPHARMA) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Bal Pharma Share Price rise today?
Ans. The supplied data confirms that Bal Pharma Share Price rose 9.70% today, but it does not establish a company-specific catalyst. The stock closed at Rs 110, up from Rs 100.27, and finished at the day’s high.
What is Bal Pharma Share Price today?
Ans. Bal Pharma Share Price today is Rs 110. The stock gained Rs 9.73, or 9.70%, during the session and moved from an opening price of Rs 101.99 to a close at the day’s high.
What is Bal Pharma’s market capitalisation?
Ans. Bal Pharma’s market capitalisation is Rs 159.64 crore. That figure places the company well below the same-industry median market cap of Rs 701.78 crore across 204 pharmaceuticals and drugs companies.
How does Bal Pharma compare on valuation?
Ans. Bal Pharma’s P/E ratio is 22.15 and its P/B ratio is 1.91. Both are below the same-industry medians of 32.87 and 3.08, based on the supplied healthcare benchmark set. The company trades at a P/E ratio of 22.15x.
What do Bal Pharma’s profitability ratios show?
Ans. Bal Pharma reports ROE of 7.92 and ROCE of 9.78. Both are below the same-industry medians of 11.7 and 13.46, which suggests the company trails the broader benchmark on these return measures.
What are Bal Pharma’s EPS, book value and dividend yield?
Ans. Bal Pharma has EPS of Rs 4.53, book value of Rs 52.36 per share and dividend yield of 1.2%. These figures help frame earnings, accounting net worth and the historical payout context behind Bal Pharma Share Price.
Which sector does Bal Pharma belong to?
Ans. Bal Pharma belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. That classification is important for Bal Pharma Share Price analysis because valuation and profitability are best interpreted against direct industry peers.
